2024
DOI: 10.1039/d3qo01931d
|View full text |Cite
|
Sign up to set email alerts
|

C–H borylation: a tool for molecular diversification

Saikat Guria,
Mirja Md Mahamudul Hassan,
Buddhadeb Chattopadhyay

Abstract: Iridium-catalyzed C-H activation and borylation witnessed as a powerful synthetic tool in the past few decades because of the widespread applicability and versatility of organoboron compounds. Nowadays, this reaction has...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 152 publications
0
1
0
Order By: Relevance
“…Among the various methods, transition-metal-catalyzed C–H borylation stands out 1–6 due to its versatility in converting C–B bonds into C–N, C–D, C–O, C–X, and C–C bonds. 7 In addition, organoboron compounds are widely used in biomarker discovery, 8,9 chemical sensing, 10 bioprobe development, 11 and molecular imaging. 12 Moreover, advancements in boron chemistry have propelled the use of boron-containing compounds in drug discovery, 13,14 exemplified by bortezomib, 15 the first FDA-approved boron-containing drug for treating multiple myeloma.…”
mentioning
confidence: 99%
“…Among the various methods, transition-metal-catalyzed C–H borylation stands out 1–6 due to its versatility in converting C–B bonds into C–N, C–D, C–O, C–X, and C–C bonds. 7 In addition, organoboron compounds are widely used in biomarker discovery, 8,9 chemical sensing, 10 bioprobe development, 11 and molecular imaging. 12 Moreover, advancements in boron chemistry have propelled the use of boron-containing compounds in drug discovery, 13,14 exemplified by bortezomib, 15 the first FDA-approved boron-containing drug for treating multiple myeloma.…”
mentioning
confidence: 99%